ivermectin (IVM)

DRUG2 trials

Sponsors

London School of Hygiene and Tropical Medicine, University of Baghdad

Conditions

COVID 19Malaria

Phase 1

Effectiveness of Ivermectin as add-on Therapy in COVID-19 Management

CompletedNCT04343092

University of BaghdadCOVID 19

Start: 2020-04-18End: 2020-06-01Updated: 2020-11-04

Phase 3

Mass Drug Administration of Ivermectin and Dihydroartemisinin-piperaquine as an Additional Intervention for Malaria Elimination

CompletedNCT03576313

London School of Hygiene and Tropical MedicineMalaria

Start: 2018-08-11End: 2021-07-31Updated: 2022-03-14

Related Papers

Risk factors for non-participation in ivermectin and dihydroartemisinin-piperaquine mass drug administration for malaria control in the MASSIV trial.

2024-02-22

Mass drug administration of ivermectin and dihydroartemisinin-piperaquine against malaria in settings with high coverage of standard control interventions: a cluster-randomised controlled trial in The Gambia.

2021-12-1549 citations

Mass Drug Administration With High-Dose Ivermectin and Dihydroartemisinin-Piperaquine for Malaria Elimination in an Area of Low Transmission With High Coverage of Malaria Control Interventions: Protocol for the MASSIV Cluster Randomized Clinical Trial

JMIR Research Protocols2020-08-0324 citations